KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. by Gloyn, A, Diatloff-Zito, C, Edghill, E, Bellanné-Chantelot, C, Nivot, S, Coutant, R, Ellard, S, Hattersley, A, Robert, J